Swab Testing to Optimize Pneumonia Treatment with Empiric Vancomycin

NACompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

February 4, 2025

Study Completion Date

February 27, 2025

Conditions
Community-acquired Pneumonia
Interventions
DIAGNOSTIC_TEST

MRSA Nasal Swab PCR

For the subjects assigned to the intervention group who have a negative MRSA nasal swab PCR result, providers will receive a pager alert which inform them of the negative result and will direct clinicians to clinical guidance recommending clinicians to discontinue vancomycin, if clinically appropriate.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT06272994 - Swab Testing to Optimize Pneumonia Treatment with Empiric Vancomycin | Biotech Hunter | Biotech Hunter